John Lubniewski

Currently holds a position at HTG Molecular Diagnostics Inc

Position	Company	Period
President, Chief Executive Officer, Director	HTG Molecular Diagnostics Inc	March 28, 2019 -
President, Chief Operating Officer	HTG Molecular Diagnostics Inc	April 10, 2018 - March 28, 2019
Chief Business Officer	HTG Molecular Diagnostics Inc	April 1, 2011 - April 10, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2016-03-14	2016-03-14	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	72,920 +40.4% 156.94 US$4,106,669	72,920 +40.4%	156.94	US$4,106,669
2016-03-14	2016-03-11	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	16,590 +22.7% 367.71 US$2,711,724	16,590 +22.7%	367.71	US$2,711,724
2016-03-14	2016-03-10	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	19,874 -17.1% 355.76 US$3,819,327	19,874 -17.1%	355.76	US$3,819,327
2016-03-09	2016-03-09	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	4,067 -11.1% 2.69 US$10,927	4,067 -11.1%	2.69	US$10,927